Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions

Layla Van Doren; Marlene Steinheiser; Kristen Boykin; Kristine J Taylor; Monica Menendez; Michael Auerbach

doi:10.1002/ajh.27220

Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions

Am J Hematol. 2024 Jan 29. doi: 10.1002/ajh.27220. Online ahead of print.

Authors

Layla Van Doren¹, Marlene Steinheiser², Kristen Boykin³, Kristine J Taylor⁴, Monica Menendez⁵, Michael Auerbach⁶

Affiliations

¹ Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
² Infusion Nurses Society, Norwood, Massachusetts, USA.
³ Florida Cancer Specialists and Research Institute, Florida, USA.
⁴ Parkview Packnett Cancer Center, Fort Wayne, Indiana, USA.
⁵ FEM Iron Infusion Centers by Heme Onc Call, Miami, Florida, USA.
⁶ Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.

PMID: 38282557
DOI: 10.1002/ajh.27220

Abstract

Intravenous iron has become an essential component for the treatment of iron deficiency and iron deficiency anemia. Individuals administering Intravenous iron should have knowledge in intravenous iron administration, including a pre-infusion assessment to evaluate infusion reaction risks, pre- and post-infusion monitoring, identification of and management of infusion reactions, accurate documentation of these reactions, laboratory monitoring and recognition and management of treatment-emergent hypophosphatemia. This comprehensive consensus provides step-by-step guidance and tools for practitioners to promote safe delivery of intravenous iron, recognition, and management of infusion reactions and treatment-emergent hypophosphatemia.

Publication types

Review

Grants and funding

G0033/Pharmacosmos